Feed Preview

Alzheimer's Disease: Early Markers

Alzheimer's Disease: Early Markers diagram by Designua,  Shutterstock
Designua, Shutterstock

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on early markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Top 20 most recent papers
Nature Communications

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease

Nature CommunicationsApril 5, 2020
Shorena JanelidzeOskar Hansson
Alzheimer's Research & Therapy

Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging

Alzheimer's Research & TherapyApril 3, 2020
James D DoeckeAIBL Research Group
Current Biology : CB

Amyloid Beta Secreted during Consolidation Prevents Memory Malleability

Current Biology : CBApril 4, 2020
Peter S B Finnie, Karim Nader
26
Dementia and Geriatric Cognitive Disorders

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

Dementia and Geriatric Cognitive DisordersApril 1, 2020
Leo BoelaartsPhilip Scheltens
2
1
Nature Reviews. Nephrology

Mechanisms of cognitive dysfunction in CKD

Nature Reviews. NephrologyApril 3, 2020
Davide ViggianoGiovambattista Capasso
8
Biological Psychiatry

The β-Secretase BACE1 in Alzheimer's Disease

Biological PsychiatryApril 1, 2020
Harald HampelAndrea Vergallo
1
1
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association

Rural Caregivers: Identification of Informational Needs Through Telemedicine Questions

The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care AssociationApril 5, 2020
Shoshana H BardachGregory A Jicha
Epigenetics : Official Journal of the DNA Methylation Society

Early epigenetic changes of Alzheimer's disease in the human hippocampus

Epigenetics : Official Journal of the DNA Methylation SocietyApril 3, 2020
Idoia Blanco-LuquinMaite Mendioroz
4
International Journal of Molecular Sciences

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines

International Journal of Molecular SciencesApril 5, 2020
Masaru TanakaLászló Vécsei
The Journal of Prevention of Alzheimer's Disease

Integrated Care for Older People and the Implementation in the INSPIRE Care Cohort

The Journal of Prevention of Alzheimer's DiseaseApril 3, 2020
C TakedaI Araujo de Carvalho
20
Journal of Clinical and Experimental Neuropsychology

Memory of decisions: Relationship between decline of autobiographical memory and temporal discounting in Alzheimer's disease

Journal of Clinical and Experimental NeuropsychologyApril 1, 2020
Mohamad El HajPhilippe Allain
1
Ageing Research Reviews

Functional roles of circular RNAs in Alzheimer's disease

Ageing Research ReviewsApril 3, 2020
Jin-Lan HuangDeng-Pan Wu
BMC Medical Genomics

Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer's disease

BMC Medical GenomicsApril 4, 2020
Yurika UpadhyayaFor The Alzheimer's Disease Neuroimaging Initiative
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of AustralasiaApril 1, 2020
Yasemin GündüztepeÖzcan Erel

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-early-markers/3f21ed1f-09e4-44f3-b22b-8e0c54be37b6